PROF (STOCKS)
Profound Medical Corp. Common Stock
$6.710000
+0.085000 (+1.28%)
Prev close: $6.625000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Arun S. Menawat
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $245.89M
- Employees
- 142
- P/E (TTM)
- -5.38
- P/B (TTM)
- 4.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.19 | $-0.26 | +0.0659 | +25.75% |
|
Dec 2025 (Q4)
|
$-0.27 | $-0.27 | -0.0007 | -0.26% |
|
Sep 2025 (Q3)
|
$-0.26 | $-0.37 | +0.1087 | +29.48% |
|
Jun 2025 (Q2)
|
$-0.52 | $-0.37 | -0.1488 | -40.09% |
Financial Statements
| Revenues | $18.81M |
| Benefits Costs and Expenses | $57.48M |
| Cost Of Revenue | $5.44M |
| Costs And Expenses | $57.48M |
| Gross Profit | $13.37M |
| Nonoperating Income/Loss | -$555.00K |
| Operating Expenses | $51.48M |
| Selling, General, and Administrative Expenses | $30.43M |
| Research and Development | $21.05M |
| Operating Income/Loss | -$38.11M |
| Income/Loss From Continuing Operations After Tax | -$38.90M |
| Income/Loss From Continuing Operations Before Tax | -$38.66M |
| Income Tax Expense/Benefit | $236.00K |
| Income Tax Expense/Benefit, Current | $217.00K |
| Income Tax Expense/Benefit, Deferred | $19.00K |
| Net Income/Loss | -$38.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.90M |
| Net Income/Loss Available To Common Stockholders, Basic | $60.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$99.25M |
| Preferred Stock Dividends And Other Adjustments | -$99.25M |
| Basic Earnings Per Share | $1.24 |
| Diluted Earnings Per Share | $1.24 |
| Basic Average Shares | 96,568,720 |
| Diluted Average Shares | 96,568,720 |
| Assets | $73.46M |
| Current Assets | $69.53M |
| Inventory | $9.00M |
| Other Current Assets | $60.53M |
| Noncurrent Assets | $3.93M |
| Fixed Assets | $682.00K |
| Other Non-current Assets | $3.24M |
| Liabilities | $14.03M |
| Current Liabilities | $10.61M |
| Accounts Payable | $2.14M |
| Wages | $1.70M |
| Other Current Liabilities | $6.76M |
| Noncurrent Liabilities | $3.43M |
| Long-term Debt | $4.50M |
| Equity | $59.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $59.42M |
| Liabilities And Equity | $73.46M |
| Net Cash Flow From Operating Activities | -$38.51M |
| Net Cash Flow From Operating Activities, Continuing | -$38.51M |
| Net Cash Flow | -$5.89M |
| Net Cash Flow, Continuing | -$5.89M |
| Comprehensive Income/Loss | -$40.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.73M |
| Other Comprehensive Income/Loss | -$9.52M |